Skip to main content

Deer IX & Co. Ltd.

SEC CIK
0001655220
Latest filing
Nov 15, 2021

The latest 13F from Deer IX & Co. Ltd. covers Q3 2021 (filed Nov 15, 2021): 6 long positions worth $971.4M. The top 10 holdings make up 100.0% of the portfolio, and the largest is NeueHealth, Inc. (NEUE) at 48.9%. Livermore has 4 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q3 2021

Share counts compared with Q2 2021: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
4
Est. +$460.4M
Added
0
Reduced
1
Est. −$36.4M
Sold out
1
Est. −$46.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. NEUENeueHealth, Inc.
    48.9%$474.8MHistory
  2. Velo3D, Inc.92259N104
    29.4%$285.2M
  3. OTMOOtonomo Technologies Ltd.
    8.6%$83.8MHistory
  4. SPIRSpire Global, Inc.
    8.4%$82.1MHistory
  5. KYMRKymera Therapeutics, Inc.
    3.7%$36.2MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. Velo3D, Inc.92259N104
    +$285.2MNew
  2. OTMOOtonomo Technologies Ltd.
    +$83.8MNewHistory
  3. SPIRSpire Global, Inc.
    +$82.1MNewHistory
  4. TCRXTScan Therapeutics, Inc.
    +$9.35MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Velo3D, Inc.92259N104
    +29.36 pp0.0% → 29.4%
  2. OTMOOtonomo Technologies Ltd.
    +8.62 pp0.0% → 8.6%History
  3. SPIRSpire Global, Inc.
    +8.45 pp0.0% → 8.4%History
  4. TCRXTScan Therapeutics, Inc.
    +0.96 pp0.0% → 1.0%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. NCNOnCino, Inc.
    −$46.8MSold outHistory
  2. KYMRKymera Therapeutics, Inc.
    −$36.4MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. NCNOnCino, Inc.
    −4.24 pp4.2% → 0.0%History
  2. KYMRKymera Therapeutics, Inc.
    −1.70 pp5.4% → 3.7%History

Metrics

13F metrics for Q3 2021, computed only from the numbers in the filings. Definitions below.

Portfolio value
$971.4M
−$133.8M (−12.1%) vs. prior quarter
Positions
6
+3 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
8.0%
Q3 2021, one quarter
Average holding period
1.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

3 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.11B (Q2 2021)

Q1 2021: $116.7MQ2 2021: $1.11BQ3 2021: $971.4M
Q1 2021Q3 2021
13F filings of Deer IX & Co. Ltd. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2021Nov 15, 20216$971.4MNEUEVelo3D, Inc.OTMOvs. Q2 2021SEC
Q2 2021Nov 24, 2021Amended3$1.11BNEUEKYMRNCNOvs. Q1 2021SEC
Q1 2021May 14, 20212$116.7MKYMRNCNO–SEC

13D and 13G filings

Companies where Deer IX & Co. Ltd. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Deer IX & Co. Ltd. does not currently report owning 5% or more of any company.

Latest filings

9 filings on file made by Deer IX & Co. Ltd. or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Deer IX & Co. Ltd.
CompanyFiled (ET)FilerFormStakeChangeEvent dateFiling
ACVAACV Auctions Inc.Feb 14, 20255:10 PM ETBessemer Venture Partners IX L.P.and 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
WEAVWeave Communications, Inc.Feb 14, 20254:58 PM ETDeer IX & Co. Ltd.and 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
VELOVelo3D, Inc.Feb 14, 20254:57 PM ETDeer IX & Co. Ltd.and 3 others13D/A0.50%1.08M shares–Below 5%Dec 24, 2024SEC
OTMOOtonomo Technologies Ltd.Sep 14, 2022Deer IX & Co. Ltd.13D/AOld format–––SEC
WEAVWeave Communications, Inc.Feb 15, 2022Deer IX & Co. Ltd.13GOld format–New–SEC
TCRXTScan Therapeutics, Inc.Feb 14, 2022Deer IX & Co. Ltd.13GOld format–New–SEC
VELOVelo3D, Inc.Oct 12, 2021Deer IX & Co. Ltd.13DOld format–New–SEC
SPIRSpire Global, Inc.Aug 25, 2021Deer IX & Co. Ltd.13GOld format–New–SEC
OTMOOtonomo Technologies Ltd.Aug 23, 2021Deer IX & Co. Ltd.13DOld format–New–SEC